EUPHIX (www.euphix.org)

EUPHIX, European Public Health Information, Knowledge & Data Management System
Diabetes

Prevalence (%) of diabetes in 2007 and estimates for 2025 in Iceland, Norway, Switzerland and the EU-27 (source: IDF, 2006b)

National

2007

Comparative

2007

National

2025

Comparative

2025

Data neighbour country used

Data source country

Austria

11.1

7.9

13.2

9.4

yes

Germany

Belgium

7.9

5.2

9.7

6.6

yes

Netherlands

Bulgaria

10.1

7.6

11.5

8.9

yes

Turkey

Cyprus

10.3

8.9

11.3

10.1

no

Cyprus

Czech Republic

9.7

7.6

11.6

8.7

yes

Poland

Denmark

7.5

5.5

11.4

8.5

no

Denmark

Estonia

9.9

7.6

10.8

8.7

yes

Poland

Finland

8.4

5.9

10.0

6.9

no

Finland

France

8.4

5.9

10.4

7.3

no

France

Germany

11.8

7.9

13.3

9.4

no

Germany

Greece

8.6

5.9

9.7

7.0

no

Greece

Hungary

9.8

7.6

11.2

8.7

yes

Poland

Iceland

2

1.6

2.5

1.9

no

Iceland

Ireland

5.6

5.1

6.4

5.9

no

Ireland

Italy

8.7

5.8

10.4

6.9

no

Italy

Latvia

10.0

7.6

11.0

8.7

yes

Poland

Lithuania

9.7

7.6

10.7

8.7

yes

Poland

Luxembourg

6.9

5.2

8.2

6.6

yes

Netherlands

Malta

9.7

6.7

11.6

8.2

no

Malta

Netherlands

7.3

5.2

9.6

6.6

no

Netherlands

Norway

4.7

3.6

5.4

4.1

no

Norway

Poland

9.1

7.6

11.0

8.7

no

Poland

Portugal

8.2

5.7

9.8

7.1

yes

Spain

Romania

9.4

7.6

10.7

8.7

yes

Poland

Slovakia

8.8

7.6

10.8

8.7

yes

Poland

Slovenia

9.8

7.6

11.8

8.7

yes

Poland

Spain

7.5

5.7

9.7

7.1

no

Spain

Sweden

7.2

5.2

8.1

6.0

no

Sweden

Switzerland

11.2

7.9

13.3

9.4

yes

Germany

United Kingdom

4.0

2.9

4.6

3.5

no

United Kingdom

EU-15

8.4

9.9

EU-25

8.5

10.1

EU-27

8.6

10.2

Remarks

All comparisons between countries should be done using the comparative prevalence, which is adjusted to the world population.

The data for diabetes rates include both type 1 and type 2 diabetes.

The prevalence of diabetes includes both undiagnosed and previously diagnosed diabetes.

Prevalence studies were based on different diagnositc criteria (WHO-1985, WHO-1999 and ADA-1997). Most studies were based on the WHO-1985 diagnostic criteria.

The oral glucose tolerance test (OGTT) was the preferred method of screening, followed by two-hour blood glucose alone, then the fasting blood glucose alone and then self-report. Studies from France, Germany Italy, the Netherlands and Norway only provided data on self-reported diabetes. To account for undiagnosed diabetes the prevalence of diabetes was doubled for these countries.

The data give an indication of the burden of diabetes in each country, but comparisons between countries should be made with caution because where no data for countries were available, the prevalence rates of neighbour countries of similar ethnicity and economic circumstances were applied to the population distribution of countries without data.